Back
Shift4 Payments Vs. Avidity Biosciences Industry Stock Comparison
Buy
84
FOUR
Shift4 Payments
Last Price:
85.90
Seasonality Move:
10.33%
Sell
31
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-1.3%
Buy
84
Shift4 Payments (FOUR)
is a Buy
Is Shift4 Payments a Buy, Sell or Hold?
- The current Shift4 Payments [FOUR] share price is $83.58. The Score for FOUR is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- FOUR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
31
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $44.64. The Score for RNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FOUR Stock Price Chart
What is Shift4 Payments's stock price today?
-
The Shift4 Payments share price today is $83.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOUR is experiencing slight selling pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $44.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
FOUR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.07 | Buy |
| Relative Strength Index (14 RSI): | 64.33 | Buy |
| Chaikin Money Flow: | -63738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (77.76 - 82.62) | Buy |
| Bollinger Bands (100): | (64.39 - 77.79) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 58.78 | Buy |
| Chaikin Money Flow: | 2358339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.17 - 44.49) | Buy |
| Bollinger Bands (100): | (30.01 - 45.23) | Buy |
FOUR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.48 | Buy |
| 20-day SMA: | 80.02 | Buy |
| 50-day SMA: | 74.34 | Buy |
| 200-day SMA: | 71.66 | Buy |
| 8-day EMA: | 81.56 | Buy |
| 20-day EMA: | 79.56 | Buy |
| 50-day EMA: | 76.1 | Buy |
| 200-day EMA: | 70.45 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.71 | Buy |
| 20-day SMA: | 42.36 | Buy |
| 50-day SMA: | 43.76 | Buy |
| 200-day SMA: | 26.77 | Buy |
| 8-day EMA: | 42.29 | Buy |
| 20-day EMA: | 42.39 | Buy |
| 50-day EMA: | 41.68 | Buy |
| 200-day EMA: | 30.34 | Buy |
Shift4 Payments Earnings Growth & FOUR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.32 per share, an increase this year of $0.90 per share, and an increase next year of $1.10 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
Shift4 Payments Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||